60
OCCUPATIONAL EXPOSURE TO BLOODBORNE PATHOGENS By DR Mohammad Abou el ela Professor of Medical Microbiology & Immunology , Mansoura Faculty of Medicine INFECTION CONTROL MEASURES FOR PREVENTION OF

INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

OCCUPATIONAL EXPOSURE TO BLOODBORNE

PATHOGENS

By

DR Mohammad Abou el elaProfessor of Medical Microbiology & Immunology , Mansoura Faculty of Medicine

INFECTION CONTROL MEASURES FOR

PREVENTION OF

Page 2: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

Goals of the presentation

1- Why are standards needed2- Who is covered by standards3- How does exposure occurs 4- Definitions5- Measures

- Engineering control- Exposure control plan- Work practice control- Personal protective equipments - Housekeeping- Labels

Page 3: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

WHY IS A STANDARD NEEDED?

Occupational Safety and Health Administration (OSHA) estimatesthat 8 million workers in the health care industry and relatedoccupations are at risk of occupational exposure to blood bornepathogens including, but not limited to, Human ImmunodeficiencyVirus (HIV – the virus that causes AIDS), Hepatitis B Virus (HBV)and Hepatitis C Virus (HCV).

According to the Centers For Disease Control (CDC), 100,000Americans have died from AIDS and over 1 million Americans areinfected with HIV.

About 65 cases of HIV infection due to occupational exposureoccur each year.

Page 4: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

WHY IS A STANDARD NEEDED? About 8,700 healthcare workers are infected with Hepatitis Beach year.

About 200 healthcare workers die from Hepatitis B each year.

One milliliter of blood can contain over 100,000,000 infectiousdoses of Hepatitis B virus.

60–70 % of the individuals infected with Hepatitis C virus showno discernable symptoms.

According to the Centers for Disease Control and Prevention(CDC), Hepatitis C virus (HCV) infection is the most commonchronic blood borne infection in the U.S.

Page 5: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

WHO IS COVERED BY THE STANDARD?

All employees who could be “reasonablyanticipated” as the result of performing theirassigned job duties to face contact withblood or other potentially infectiousmaterials.

“Good Samaritan” acts, such as assisting aco-worker with a nosebleed, would not beconsidered occupational exposure.

Page 6: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

SOME WORKERS WHO ARE AT RISK

Physicians

Nurses

Emergency Room Personnel

Orderlies

Housekeeping Personnel

Laundry Workers

Laboratory Personnel

Blood Bank Personnel

Medical Examiners

Dentists and Dental Workers

Morticians

Law Enforcement Personnel

Firefighters

Paramedics

Emergency Medical Technicians

Medical Waste Handlers

Home Healthcare Workers

Employees assigned to first-aid response duties by their employer

Other workers assigned duties putting them at risk of occupational exposure

Page 7: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

HOW DOES EXPOSURE OCCUR?

Needle sticks (most common)- 800,000 needle stick injuries occur each year in

the U.S.

Cuts from other contaminated sharps(scalpels, broken glass, etc.)

Contaminated blood contact with theeyes, mucous membranes of the mouthor nose, or broken (cut or abraded) skin

Page 8: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

Needle Stick Injury and Accidental Exposure to BloodRisks

Accidental exposure to blood caused by needle injuries or injuries following, cutting, biting or splashing incidents carries the risk of

infection by blood-borne viruses such as the hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

HBV risk= 5 - 40%HCV risk= 3 - 10%

HIV risk = 0.2 - 0.5%

Page 9: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

Immediate action after injury:

• (1) Taking care of the wound immediately after the accident

• Let the wound bleed for a moment and then cleanse thoroughly with water or a saline solution.

• Disinfect the wound using an ample amount of soap and water followed by 70% alcohol.

• In case of contact with mucous membranes it is important to rinse immediately and thoroughly, using water or a saline solution only, not alcohol.

Page 10: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

Continue• (2) Reporting the incident• It is important to report the incident immediately to the

infection control team. This will allow proper registration and subsequent management of the event.

• (3) Immediate action (dealing with the potential source)

• If the source of the blood is known the patient must be asked for permission to sample blood for a HBs Ag, HCV and HIV test.

• If the patient refuses then it must be assumed the patient is a carrier of the virus.

• If the origin of the blood is unknown then any blood present should be considered infected.

• (4) Immediate action (injured person)• A blood sample should be taken as soon as possible after the

injury.

Page 11: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

Treatment approaches

• Management is based on finding out whether there is a risk of HBV, HCV or HIV depending on the serological analysis of the sample.

• What to do after a potential HBV infection • Management of the situation is based on whether or not the injured

person is immune for HBV, either as a result of vaccination or otherwise. There are two possibilities:

• Subject has full immunity, if: • the person has had at least three vaccinations against HBV plus a

subsequent check for antibodies • the person has had hepatitis B in the past.• the anti HBs ab is more than 100 IU/l • In this case, the injured person need not receive any

prophylaxis.

Page 12: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

Subject has a partial immunity, if:

• there was only a limited vaccination against HBV (dose was not completed).

• the anti HBs Ab is 10-100 IU/l • In this case the injured person needs to receive 5 ml

intramuscular hepatitis B immunoglobulin (HBIG) which should be given within 48 hours of the injury + booster dose of the hepatitis B vaccine.

• Subject has no immunity, if• There was no vaccination against HBV at all in the past.• the anti HBs ab is below 10 IU/l • Should this be the case then 5 ml intramuscular

hepatitis B immunoglobulin (HBIG) should be given within 48 hours of the injury + HB vaccine in three doses separated by one week interval.

Page 13: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

What to do after a potential HCV infection

• There is no effective drug prophylaxis for HCV.• The injured person should receive a polyvalent IG given within

48 hours of the injury.• The case should be followed closely for 12 months and a

serological examination for HCV should be done after 2, 6 and 12 months of the incident.

• If one of these follow up analyses finds HCV antibodies, the level of liver enzymes should be followed up every two months.

• In case of a positive HCV case, a combination treatment of interferon and ribavirin is the treatment of choice. A liver specialist should be consulted.

Page 14: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

DEFINITIONS

“Blood” means human blood, human bloodcomponents, and products made from humanblood.

Human blood components includes plasma, platelets, and

serosanguineous fluids (e.g. exudates from wounds).

Also included are medications derived from blood, such asimmune globulins, albumin, and factors 8 and 9.

Page 15: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

DEFINITIONS

“Blood borne Pathogens” means pathogenicmicroorganisms that are present in human bloodand can cause disease in humans. Thesepathogens include, but are not limited to,hepatitis B virus (HBV), HCV and humanimmunodeficiency virus (HIV).

While HIV and HBV are specifically identified in the standard, theterm includes any pathogenic microorganism that is present inhuman blood and can infect and cause disease in persons who areexposed to blood containing the pathogen.

Page 16: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

DEFINITIONS

“Contaminated” means the presence or thereasonably anticipated presence of blood or otherpotentially infectious materials on an item orsurface.

“Contaminated Sharps” means anycontaminated object that can penetrate the skinincluding, but not limited to, needles, scalpels,broken glass, broken capillary tubes, and exposedends of dental wires.

Page 17: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

DEFINITIONS

“Decontamination” means the use of physical orchemical means to remove, inactivate, or destroyblood borne pathogens on a surface or item tothe point where they are no longer capable oftransmitting infectious particles and the surfaceor item is rendered safe for handling, use, ordisposal.

Page 18: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

DEFINITIONS

“Exposure Incident” means a specific eye, mouth,other mucous membrane, non-intact skin, orparenteral contact with blood or other potentiallyinfectious materials that results from theperformance of an employee’s duties.

Non-intact skin includes skin with dermatitis, hang-nails, cuts,abrasions, chafing, acne, etc.

Parenteral means piercing mucous membranes or the skin barrierthough such events as needle sticks, human bites, cuts, and abrasions.

When an employee experiences an “exposure incident”, theemployer must institute the required follow-up procedures in theirplan.

Page 19: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

DEFINITIONS

“Occupational Exposure” means reasonably anticipated skin, eye,mucous membrane, or parenteral contact with blood that mayresult from the performance of an employee’s duties.

Reasonably anticipated exposure includes the potential for exposure aswell as actual exposure to blood or OPIM. It includes exposure to blood orOPIM (including regulated waste) as well as incidents of needle sticks.

A determination that an employee has “occupational exposure” basedupon job assignment triggers the requirement that the employer provide,and include the affected employee in, the employer’s exposure control plan.

Employees assigned first aid response duties by their employer would beconsidered to have “occupational exposure”.

This definition does not cover “Good Samaritan” acts (i.e. voluntarilyaiding someone in one’s place of employment) which results in exposure to

blood or OPIM.

Page 20: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

DEFINITIONS

“Other Potentially Infectious Materials (OPIM)” means

1) The following human body fluids: semen, vaginal secretions,cerebrospinal fluid, synovial fluid, pleural fluid, pericardialfluid, peritoneal fluid, amniotic fluid, saliva in dentalprocedures, any body fluid that is visibly contaminated withblood, and all body fluids in situations where it is difficult orimpossible to differentiate between body fluids;

2) Any unfixed tissue or organ (other than intact skin) from ahuman (living or dead); and

3) HIV-containing cell or tissue cultures, organ cultures, andHIV-or HBV-containing culture medium or other solutions; andblood, organs, or other tissues from experimental animalsinfected with HIV or HBV.

Urine and feces are not OPIM unless, they are visibly contaminatedwith blood.

Page 21: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

DEFINITIONS

*“Engineering Controls” means controls (e.g.,sharps disposal containers, self-sheathingneedles, safer medical devices, such as sharpswith engineered sharps injury protections andneedle less systems) that isolate or remove theblood borne pathogens hazard from theworkplace.

Page 22: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

DEFINITIONS

*”Needle less Systems” means a device that does not use needles for:

1) The collection of bodily fluids or withdrawal of body fluidsafter initial venous or arterial access is established;

2) The administration of medication or fluids: or

3) Any other procedure involving the potential foroccupational exposure to blood borne pathogens dueto percutaneous injuries from contaminated sharps.

Examples:

-intravenous medication delivery systems that administermedications or fluids through a catheter port or connector site using ablunt cannuala or other non-needle connection,

-jet injection systems that deliver subcutaneous or intramuscularinjections of liquid medications through the skin without use of aneedle

Page 23: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

DEFINITIONS

*“Sharps with Engineered Sharps Injury Protections” means a

nonneedle sharp or needle device used for withdrawing body fluids,accessing a vein or artery, or administering medications or otherfluids, with a built-in safety feature or mechanism that effectivelyreduces the risk of an exposure incident.

Commonly referred to as SESIP’s.

Examples: syringes with guards or sliding sheaths; retractable needlesyringes; shielded or retracting catheters; delivery systems using catheterports or connector sites using a needle that is housed in a protectivecovering; blunt suture needles; plastic (not glass) capillary tubes.

Page 24: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

ENGINEERING CONTROLS –Hypodermic Syringes which contain the Hazard

Syringe with Retractable Needle

After the needle is used, an extra push on the plungerretracts the needle into the syringe, removing the hazardof needle exposure.

Page 25: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

ENGINEERING CONTROLS –Hypodermic Syringes which contain the Hazard

Self Re-Sheathing Needles

Initially, the sleeve is located over the barrel of the syringe with theneedle exposed for use. After the device is used, the user slides thesleeve forward over the needle where it locks in place and provides aguard around the used needle. Some designs have a shield which mustbe twisted to engage the lock. This type of device is also available onphlebotomy blood tube holders.

Page 26: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

ENGINEERING CONTROLS –Hypodermic Syringes which contain the Hazard

"Add on" Safety Feature

Hinged or sliding shields attached to syringes, phlebotomy needles,winged steel needles, and blood gas needles.

Page 27: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

ENGINEERING CONTROLS –Blood Tube Holders which contain the Hazard

Blunting Needle

After use, a blunt internal cannula is activated which moves theblunt tip needle forward through the hollow needle and past thesharp needle point. The blunt point tip of this needle can beactivated before it is removed from the vein or artery. This typeof device is available on hypodermic syringes and phlebotomyblood tube holders.

Page 28: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

ENGINEERING CONTROLS –Scalpels which contain the Hazard

Re-Sheathing Disposable Scalpels

Single-use disposable scalpels have a shield that is advancedforward over the blade after use, containing and removing thehazard.

Page 29: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

ENGINEERING CONTROLS –Lancets which contain the Hazard

Retracting Finger/Heal Lancet

This single use lancetautomatically retractsafter use, containingand removing thehazard.

Page 30: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

ENGINEERING CONTROLS –Vascular Access Device which contains the Hazard

Blunting Winged Steel Needles

After placement, the third wing is rotated to flat position which blunts the needle point before it is removed from the patient.

Page 32: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

EXPOSURE CONTROL PLAN

To eliminate or minimize employee exposure to bloodand OPIM, the employer is required to develop a writtenExposure Control Plan.

The Exposure Control Plan is akey provision of the standard.

It requires the employer toidentify employees who willreceive the training, protectiveequipment, vaccination, andother provisions of thestandard.

Page 33: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

EXPOSURE CONTROL PLAN

The Exposure Control Plan shall be reviewed and updatedat least annually and whenever necessary to reflectnew or modified tasks and procedures which affectoccupational exposure and to reflect new or revisedemployee positions with occupational exposure. Thereview and update of such plans shall also:

(A) Reflect changes in technology to eliminate or reduceexposure to blood borne pathogens; and

(B) Document annually consideration and implementationof appropriately commercially available and effectivesafer medical devices designed to eliminate orminimize occupational exposure.

Page 34: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

UNIVERSAL PRECAUTIONS

Universal precautions shall be observed toprevent contact with blood or OPIM. Undercircumstances in which differentiation betweenbody fluid types is difficult or impossible, all bodyfluids shall be considered potentially infectiousmaterials.

“Universal Precautions” is an approach to infection control. According to theconcept, all human blood and certain human body fluids are treated as ifknown to be infectious for HIV, HBV, and other blood borne pathogens.

Assume the above status regardless of the perceived “low risk” status of apatient or patient population.

Page 35: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

ENGINEERING AND WORK PRACTICE CONTROLS

Engineering and work practice controls shall be used toeliminate or minimize employee exposure.

These are the primary methods used to control the transmissionof blood borne pathogens.

Engineering and work practice controls shall be used inpreference to other methods as a good industrial hygiene practice.

When occupational exposure remains after engineering and workpractice controls are put in place, personal protective equipment(PPE) must be used.

Page 36: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

ENGINEERING CONTROLS

These controls reduce employee exposure by either

removing the hazard or isolating the worker.

Page 37: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

ENGINEERING CONTROL EXAMPLES

Sharps disposal containers must be provided and used.

Sharps disposal containers must be leakp roof, puncture resistant, able to be closed, and labeled or color-coded.

Page 38: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

ENGINEERING CONTROL EXAMPLES

Employers shall provide handwashing facilities which are readily accessible to employees.

When provision of hand washing facilities

is not feasible, the employer shall provide either an appropriate antiseptic hand cleanser in conjunction with clean cloth/paper towels or antiseptic towelettes.

Page 39: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

ENGINEERING CONTROL EXAMPLES

Mouthpieces and resuscitation devices must be supplied where employees are expected to perform CPR as an assigned duty.

Page 40: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

WORK PRACTICE CONTROLS

These controls reduce the likelihood of exposure by

altering how a task is performed.

Page 41: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

WORK PRACTICE CONTROLS

Wash hands after removing gloves and as soon as possible after exposure occurs.

After use, place disposable contaminated sharps in an immediately accessible sharps container (SESIPs, with the safety device activated, must still be placed in a sharps container).

Page 42: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

WORK PRACTICE CONTROLS

Prohibit the bending, recapping or removal of contaminated needles (unless the action is required by a specific medical procedure, then only through the use of a mechanical device or one-handed technique (document when and where allowed in the Exposure Control Plan)

Shearing or breaking contaminated needles is prohibited.

Page 43: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

WORK PRACTICE CONTROLS

Immediately or as soon as possible after use, contaminated reusable sharps shall be placed in puncture-resistant, leak proof and labeled or color-coded containers until properly reprocessed. (To avoid spillage of contents, it is suggested that they be covered and secured prior to moving.)

Page 44: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

WORK PRACTICE CONTROLS

Eating, drinking, smoking, applying cosmetics or lip balm, and handling contact lenses are prohibited in work areas where there is a reasonable likelihood of occupational exposure.

Page 45: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

WORK PRACTICE CONTROLS

Food and drink shall not be kept in refrigerators,

freezers, shelves, cabinets or on countertops or

bench tops where blood or OPIM are

present.

Page 46: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

WORK PRACTICE CONTROLS

All procedures involving blood or OPIM shall be performed in such a manner as to minimize splashing, spraying, spattering, and generation of droplets of these substances.

Page 47: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

WORK PRACTICE CONTROLS

Mouth pipetting/suctioning of blood or OPIM is prohibited. Use mechanical devices.

Page 48: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

WORK PRACTICE CONTROLS

Specimens of blood or OPIM shall be placed in a container which prevents leakage during collection handling, processing, storage, transport, or shipping (a secondary container is need if outside of primary container is contaminated, or if it could be punctured by the specimen).

Equipment to be serviced or shipped must be decontaminated or marked with a readily observable label.

Page 49: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

PERSONAL PROTECTIVE EQUIPMENTGloves

Gloves shall be worn when

it can be reasonably

anticipated that the

employee may:

- have hand contact with blood,

- have hand contact with OPIM,

- have hand contact with mucous membranes,

- have hand contact with non-intact skin,

- perform vascular access procedures,

- handle or touch contaminated items or surfaces.

Page 50: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

PERSONAL PROTECTIVE EQUIPMENTMasks, Eye Protection, & Face Shields

Masks in combination with eye protection devices, such as goggles or glasses with solid side shields, or chin-length face shields, shall be worn whenever splashes, spray, spatter, or droplets of blood or OPIM may be generated.

Page 51: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

PERSONAL PROTECTIVE EQUIPMENTGowns, Aprons, & Other Protective Body Clothing

Appropriate protective clothing such as, but not limited to, gowns, aprons, lab coats, clinic jackets, or similar outer garments shall be worn in occupational exposure situations. The type and characteristics will depend upon the task and degree of exposure anticipated.

Surgical caps or hoods and/or shoe covers or boots shall be worn in instances when gross contamination can reasonably be anticipated.

Page 52: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

HOUSEKEEPINGDecontamination

Work surfaces must be decontaminated with an appropriate disinfectant:

- After completion

of procedures,

- When surfaces are

contaminated, and

- At the end of the work shift if they may have become

contaminated since the last cleaning.

Page 53: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

HOUSEKEEPINGOther Issues

Contaminated broken glassware:

- shall not be picked up directly with the hands.

- shall be cleaned up using mechanical means, such as a brush

and dust pan, tongs, or forceps (Tools must be decontaminated).

- shall be placed into a sharps container for proper disposal.

Contaminated reusable sharps shall not be stored or processed in amanner that requires employees to reach by hand into the containerswhere these sharps have been placed. (For example, do not dumpcontaminated reusable sharps in a sink of soapy water and thenretrieve the devices from the sink by hand. Use a strainer basket tohold the immersed instruments, and forceps for their retrieval fromthe basket.)

Page 54: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

HOUSEKEEPINGRegulated Waste

• Regulated waste must be placed in closeable, leakproof containers built to contain all contents during handling, storing, transporting or shipping and be appropriately labeled or color-coded.

Page 55: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

HOUSEKEEPINGRegulated Waste – Sharps Containers

Sharps containers:

• must be located as close as is feasible to where sharps are used,

• must be maintained upright throughout use,

• must not be overfilled,

• must be closed prior to disposal,

• should be disposed of per Minnesota Infectious Waste Control Act requirements.

Page 56: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

HOUSEKEEPINGLaundry

Contaminated laundry shall be:

handled as little as possible,

handled with the proper PPE,

bagged or containerized at

location where it was used

and shall not be sorted or

rinsed in location of use,

placed and transported in bags which prevent any soak-through or leakage,

placed and transported in labeled or color-coded containers (except where all laundry is handled with universal precautions and recognizable as such).

Page 57: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

LABELS

The standard requires that warning labels be attached to:

Containers of regulated waste;

Refrigerators and freezers

containing blood or OPIM;

Other containers used to store,

transport, or ship blood or OPIM;

Contaminated equipment prior

to shipping.

Red bags or containers may be BIOHAZARD

substituted for labels.

Page 58: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

SIGNS

The employer shall post

the biohazard label at the

entrance to HIV and HBV

research laboratories and

production facilities. As

with signs, the label shall

be fluorescent orange or

orange-red with letters or BIOHAZARD

symbols in contrasting colors.

Page 59: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

QUESTIONS ?

Page 60: INFECTION CONTROL MEASURES FOR PREVENTION OF · 2011. 12. 18. · components, and products made from human blood. Human blood components includes plasma, platelets, and serosanguineous

THANK YOU!